Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition

Trends in Immunology(2020)10.1016/j.it.2020.08.010Source: DataRank Database

Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition is a research paper published in Trends in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 89 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

89 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: closedTopics (9)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Harvey Cantor ORCID,Kat Cosmopoulos,Hye Jung Kim ORCID

Live enrichment

PubMed:32976740

National Institutes of Health

U.S. Department of Defense

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S1471490620301873?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1471490620301873?httpAccept=text/plain

MeSH Terms

HumansNeoplasmsImmunotherapyTumor MicroenvironmentEnhancer of Zeste Homolog 2 ProteinImmune Checkpoint Inhibitors

Keywords

ImmunotherapyTumor MicroenvironmentEzh2

Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition

FAIR Checklist

Authors (3)

Funding (2 grants)

Open Access

Topics